20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure.
about
Role of the adenosine(2A) receptor-epoxyeicosatrienoic acid pathway in the development of salt-sensitive hypertensionAssociation of a CYP4A11 variant and blood pressure in black menIncreased blood pressure in mice lacking cytochrome P450 2J5A physiogenomic approach to study the regulation of blood pressureCytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology.20-Hydroxyeicosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin II and endothelin-1.The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of ChinaGene expression profiles linked to AT1 angiotensin receptors in the kidney.Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel.Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450.Effects of acetylenic epoxygenase inhibitors on recombinant cytochrome p450sCytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice.Involvement of cytochrome P-450 1B1 in renal dysfunction, injury, and inflammation associated with angiotensin II-induced hypertension in rats.Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: a novel target for antihypertensive agents.Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease.Cytochrome p450 enzymes and cardiovascular disease.Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice.CYP1A in TCDD toxicity and in physiology-with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates.Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors.Genetic associations with hypertension: meta-analyses of six candidate genetic variants.Heme oxygenase: the key to renal function regulation.Role of cytochrome P450 epoxygenase in regulating renal membrane transport and hypertension.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.A common polymorphism of CYP4A11 is associated with blood pressure in a Chinese population.The effect of omega-3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patients.Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus.Haplotype-based case-control study of CYP4A11 gene and myocardial infarction.Arachidonic acid ω-hydroxylase CYP4A11: inter-ethnic variations in the 8590T>C loss-of-function variant.A novel polymorphism of the CYP4A11 gene is associated with coronary artery disease.Cytochrome P450 metabolites of arachidonic acid are elevated in stroke patients compared with healthy controls
P2860
Q27000348-59320496-9528-4D55-B610-0514B8BF25C7Q28274987-86109703-4DE4-4634-A3D1-713FBD89FA23Q28509705-8EE0B411-4DCB-4A78-AF8F-FE90C3CABF60Q28569474-0ED74C94-5832-452C-AC2B-D20874D129BDQ34157216-D8D59F32-1621-46BA-B846-8F15F974DCF5Q34159332-F889D90D-B73C-4377-9159-EE14A559C0FBQ34246447-558E4F65-B246-4189-B7A4-18D8AB6DEB3CQ34432741-75508D70-9B6B-4ABE-9002-4B992266DBDFQ34524859-A62E3C43-489C-4B7B-B1FF-2D19CD010321Q35016255-EC0B47F4-FDD6-46B7-B7EB-D23A84407579Q35079537-92E1EB8A-BC6E-4ED5-AB29-48239DC31190Q35707118-542C21A9-2AD0-4641-9AAC-43F9E7CC18D9Q35787438-438208C0-EBB2-45F1-B050-6D05FD65188EQ35919773-E2BF9EDA-0A39-4150-AA07-8A7685C5DBCEQ35981986-D6C4F3AC-EECF-451E-9F23-B68673005FD4Q36006519-552453C8-4F7A-4F99-A601-579439730893Q36403672-D4B29DAB-C0AD-4126-B1ED-9EDACC7F80FEQ36473507-0BF46F3A-9584-4A11-A7A4-A0623FD51B96Q36861457-BF06CCA9-B1E0-444C-AE7F-8402C40E5B65Q37190345-FB293EA4-7E60-4176-9C1B-F0CBA019BDDFQ37430672-8F280123-A96A-484B-B0F9-535C82CC8208Q37483653-4BCB6618-B34C-426A-ACD7-7177E62015E7Q37995534-BB2E424B-8E6A-45A5-B0E3-8D66EC8E9DA8Q39782393-1F88252C-9230-4E87-8F75-01D21BA18BF3Q41763568-F800C5A2-E16B-4E93-A776-61C1BD782902Q46598545-646AA3E6-B642-43FB-8782-1252F50C5A55Q46749490-33A3FF8F-7FBB-49F2-BDE0-6921B613DBF3Q46948889-923C9507-AB64-4D87-975D-85445AD99151Q53665122-5DBA0C11-CE51-4B60-9742-1D879FF302EDQ57313058-71EE4991-5211-42CC-BC4E-4AF877486486
P2860
20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure.
@ast
20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure.
@en
type
label
20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure.
@ast
20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure.
@en
prefLabel
20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure.
@ast
20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure.
@en
P1476
20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure.
@en
P2093
P304
P356
10.1097/00041552-200103000-00012
P577
2001-03-01T00:00:00Z